Bristol-Myers reviews $100m US media work

- The pharmaceuticals company, Bristol-Myers Squibb, has put its estimated $100 million (£60 million) US consumer prescription drug media business up for review.

- The pharmaceuticals company, Bristol-Myers Squibb, has put its estimated $100 million (£60 million) US consumer prescription drug media business up for review.

The account is currently handle by Western International Media, California. The business includes the Pravachol cholesterol-reduction brand, which makes up the bulk of the spending, but also includes Buspar anxiety and Zerit HIV treatments.





Topics